; (2) identify how data are collected regarding DVT/PE and the adverse outcomes associated with such conditions; (3) identify how DVT/PE impacts the lives of individuals in the United States; (4) identify the standard of care for DVT/PE surveillance, detection, and treatment; (5) identify emerging treatments, therapies, and research relating to DVT/PE; (6) develop recommendations to help health care providers identify patients who may be at a higher risk of forming DVT/PE in health care facilities; (7) develop recommendations to help improve patient awareness of DVT/PE; (8) develop recommendations with respect to the standard of care for patients at risk of forming DVT/PE; (9) develop recommendations relating to providing patients and their families with written notice of increased risks of forming DVT/PE; and (10) identify the estimated level of Federal funding needed for DVT/PE services to meet the needs of high-risk populations. (c) Membership The Advisory Committee shall be composed of members appointed by the Secretary as follows: (1) At least 1 individual who has experienced blood clots. (2) At least 1 family member of an individual who died from DVT/PE. (3) At least 1 health services researcher. (4) At least 1 health care provider. (5) At least 1 representative of a health plan. (6) At least 1 representative of a hospital or health system. (7) At least 1 epidemiologist. (8) At least 1 public health expert. (9) At least 1 patient representative or representative of a patient group. (10) Such individuals representing other interested parties or associations, as the Secretary determines appropriate. (d) Report Not later than 18 months after the first meeting of the Advisory Committee, the Secretary shall submit to Congress (and make publicly available) a report— (1) summarizing the meetings and findings of the Advisory Committee